Developing a tailored digital intervention to improve adherence to statin medications
Statins are common medicines that lower cholesterol and protect against heart attacks and strokes. Even though statins save lives, up to half of all patients stop taking them within a year. People often stop because they worry about side effects, forget daily doses, or do not feel fully supported. This is especially common among under-represented communities. Researchers from Imperial College London want to change this. They are developing a personalised digital tool, such as an app or text support service, to help people stay on track with their treatment. To make sure the tool works in everyday life, researchers need patients who take statins, as well as primary care staff, to share their experiences. Taking part involves doing a 45-minute interview, joining small group workshops, and trying out the new digital tool to give feedback.
At a glance
What is this study about?
Statins are widely prescribed medicines across the UK that lower cholesterol levels in the blood. Having high cholesterol can clog blood vessels, increasing the risk of serious problems like heart attacks and strokes. Taking a statin regularly helps protect your heart and blood vessels. However, studies show that many people struggle to keep taking them long-term, and over half stop taking their tablets within two years.
There are many everyday reasons why people miss doses or stop altogether. Some people worry about potential side effects, others find it tricky to build a daily routine, and some feel they were not given enough information when their tablets were first prescribed. Research also shows that people from ethnic minority backgrounds and underprivileged areas often face even greater barriers to sticking with their medicine.
This study aims to solve these challenges by creating an easy-to-use digital support tool based on behavioural science. Rather than offering standard advice, the tool will be tailored to each person's unique lifestyle, worries, and needs. By listening closely to patients and NHS healthcare staff, the research team hopes to build a practical service that makes taking regular medication simpler and more reassuring for everyone.
Key takeaways
- The study aims to create a digital support tool to help people take their statins regularly.
- Open to adults aged 18 and older who have been prescribed statin medication.
- Researchers especially welcome voices from ethnic minority and lower-income backgrounds.
- Involves informal interviews, workshops, and testing a tool on your phone—no medicine changes.
- Sessions can be completed online or in person to fit around your daily schedule.
Who may be eligible?
This study is open to adults aged 18 and over who have been prescribed statin medication. The researchers are particularly keen to hear from people who are often under-represented in health research, such as ethnic minorities and individuals from lower-income backgrounds. Primary care professionals who regularly talk to patients about statins—including GPs, practice nurses, pharmacists, and healthcare assistants—are also eligible.
You cannot take part as a patient if you are under 18, currently pregnant, or have never been prescribed a statin. The study is also not suitable for people with severe memory or thinking problems (cognitive impairment) or those living with a severe, life-limiting illness. Participants should be able to speak English, unless an interpreter can be arranged.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you aged 18 or over?
- Have you been prescribed a statin by a doctor?
- Are you able to speak English or use an interpreter?
- Are you comfortable sharing your thoughts in an interview or workshop?
- Are you currently not pregnant?
What does participation involve?
Taking part does not involve testing any new medicines—you will continue taking your normal statin exactly as prescribed by your doctor. The study is focused entirely on sharing your thoughts and helping design the new digital tool.
Your participation starts with a 45-minute one-to-one interview, which can be done online or in person at a time that suits you. Next, you may be invited to take part in up to six two-hour workshops with other patients and healthcare staff to help build the tool. These workshops include regular breaks and take place either online or in person during evenings or daytime hours. Finally, you will test the tool on your smartphone for a short time, complete a quick feedback questionnaire, and attend a one-hour focus group to discuss your experience. The full project runs until June 2026, but your personal involvement will only involve a few sessions across several weeks.
Potential risks and benefits
Locations (2)
- Imperial College LondonApproximateLondon, England
- Richford Gate Medical CentreApproximateLondon, England
Common questions
Will I have to switch or stop my current statin tablets?
No. You will continue to take your normal prescribed statins exactly as directed by your GP. This study tests a communication and support tool, not a new medicine.
Do I need to travel to attend the study sessions?
No. All interviews, workshops, and focus groups can be completed online from home, though in-person options are also available if you prefer.
What kind of technology do I need to take part?
You will only need a basic smartphone, tablet, or computer with an internet connection to join video calls and try out the digital tool.
Can I leave the study if I change my mind?
Yes. You can leave the study at any point without giving an explanation. Leaving will not affect the healthcare you receive from your GP or the NHS.
Who is running and funding this research?
The study is led by researchers at Imperial College London alongside GP practices in Hammersmith and Fulham, with funding from the National Institute for Health and Care Research (NIHR).
How to find out more
Javiera Rosenberg
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.